The NLCFN has been contacted by the trial coordinator for the SARON trial based at CRUK &; UCL Cancer Trials Centre (UCL CTC) in London. They are looking at opportunities to promote this national lung trial. The trial is funded by CRUK, sponsored by UCL and coordinated at UCL CTC. The Chief Investigator of this trial is Dr David Lindau. Currently, there are 12 centres throughout the UK with an aim of having about 30 centres in total. Information about the trial can be viewed at: http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-stereotactic-ablative-radiotherapy-for-non-small-cell-lung-cancer-saron The trial patient population is stage IV non small cell lung cancer, with metastatic disease (not more than 3 areas). SARON is a randomised trial where patients will have either chemotherapy only (standard) or chemotherapy plus radiotherapy (it could be conventional radiotherapy, or stereotactic ablative radiotherapy (SABR) and/or stereotactic radiosurgery (SRS).
Join Lung Cancer Nursing UK
Be a member of a dynamic and cohesive forum of lung cancer nurse specialists (LCNS) working throughout the UK. Membership costs just £30 per year and is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer.
Annual Conference
Join us for the LCNUK Conference 2024, the go-to event for any nurse working in lung cancer.
Held Thursday 20th - Friday 21st June at the Hilton Hotel, Glasgow. In this year’s event we’ll be returning to the fundamentals that are so important to our role focusing on patient centred care and symptom management.